Search for constituents with neurotrophic factor-potentiating activity from the medicinal plants of Paraguay and Thailand

Yakugaku Zasshi

Volumn 124, Issue 7, 2004, Pages 417-424

  Li, Yushan ^a   Ohizumi, Yasushi ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

Constituent potentiating NGF's action; Garcinia xanthochymus; Neurodegenerative disorder; PC12D cell; Scoparia dulcis; Verbena littoralis

Indexed keywords

1,2,6 TRIHYDROXY 5 METHOXY 7 (3 METHYLBUT 2 ENYL)XANTHONE; 1,3,5,6 TETRAHYDROXY 4,7,8 TRIS(3 METHYL 2 BUTENYL)XANTHONE; 1,4,5,6 TETRAHYDROXY 7,8 BIS(3 METHYLBUT 2 ENYL)XANTHONE; 12 B HYDROXY DEXTRO GARCIGERRIN A; 2ALPHA,3ALPHA DIHYDROXYURS 12 EN 28 OIC ACID; 2ALPHA,3ALPHA,19ALPHA TRIHYDROXYURS 12 EN 28 OIC ACID; 2ALPHA,3ALPHA,23 TRIHYDROXYOLEAN 12 EN 28 OIC ACID; 2ALPHA,3BETA DIHYDROXYOLEAN 12 EN 28 OIC ACID; 2ALPHA,3BETA,19ALPHA TRIHYDROXYURS 12 EN 28 OIC ACID; 3BETA HYDROXYOLEAN 11 EN 28,13BETA OLIDE; 3BETA HYDROXYURS 11 EN 28,13BETA OLIDE; 4,9 DIHYDROXY 8 METHOXY ALPHA LAPACHONE; 6 METHOXYSEMPEROSIDE; 7 A HYDROXYGELSEMIOL; 7 A HYDROXYSEMPEROSIDE AGLUCONE; 7 O ALPHA LEVO 2,3 DI O ACETYLRHAMNOPYRANOSYL (1-6) BETA DEXTRO GLUCOPYRANOSIDE; 7 O ALPHA LEVO 3 O ACETYLRHAMNOPYRANOSYL (1-6) BETA DEXTRO GLUCOPYRANOSIDE; ASIATIC ACID; GARCINIAXANTHONE E; GELSEMIOL; GELSEMIOL 6' CAFFEOYL 1 GLUCOSIDE; LITTORACHALCONE; LITTORALISONE; NEUROTROPHIC FACTOR; OLEANOLIC ACID DERIVATIVE; PLANT EXTRACT; STIGMAST 5 ENE 3BETA,7ALPHA,22ALPHA TRIOL; UNCLASSIFIED DRUG; UNINDEXED DRUG; URSOLIC ACID; VERBENACHALCONE; METHANOL; NERVE GROWTH FACTOR;

ANIMAL CELL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG ISOLATION; DRUG POTENTIATION; DRUG STRUCTURE; MEDICINAL PLANT; NERVE FIBER GROWTH; NONHUMAN; PARAGUAY; RAT; REVIEW; THAILAND; ANIMAL; CELL STRAIN; CHEMISTRY; CYTOLOGY; METABOLISM; NEURITE; PHYSIOLOGY; STIMULATION;

ANIMALS; METHANOL; NERVE GROWTH FACTOR; NEURITES; PARAGUAY; PC12 CELLS; PLANT EXTRACTS; PLANTS, MEDICINAL; RATS; STIMULATION, CHEMICAL; THAILAND;

EID: 4143099389     PISSN: 00316903     EISSN: None     Source Type: Journal    
DOI: 10.1248/yakushi.124.417     Document Type: Review

References (22)

1. Fukunaga K., Miyamoto E., Mol. Neurobiol., 16, 79-95 (1998).
2. Woodruff R. H., Franklin R. J., Histol. Histopathal., 12, 459-466 (1997).
3. Patrick C. W., Kukreti S., McIntire L. V., Exp. Neurology, 138, 277-285 (1996).
4. Levi-Montalcini R., Science, 237, 1154-1162 (1987).
5. Li P., Matsunag K., Yamamoto K., Yoshikawa R., Kawashima K., Ohizumi Y., Neurosci. Lett., 273, 53-56 (1999).
6. Obara Y., Aoki T., Kusano M., Ohizumi Y., J. Pharmacol. Exp. Ther., 301, 803811 (2002).
7. Brinton R. D., Yamazaki R. S., Pharmaceutical Res., 15, 386-398 (1998).
8. Siegel G. J., Chauhan N. B., Brain Res. Rev., 33, 199-227 (2000).
9. Connor B., Dragunow M., Brain Res. Rev., 27, 1-39 (1998).
10. Hefti F., J. Neurobiol., 25, 1418-1435 (1994).
11. Li Y., Matsunaga K., Ishibashi M., Ohizumi Y., J. Org. Chem., 66, 2165-2167 (2001).
12. Li Y., Ishibashi M., Satake M., Oshima Y., Ohizumi Y., Chem. Pharm. Bull., 59, 1103-1105 (2003).
13. Li Y., Satake M., Oshima Y., Ohizumi Y., Chem. Lett., 32, 728-729 (2003).
14. Li Y., Matsunaga K., Kato R., Ohizumi Y., J. Pharm. Pharmacol., 53, 915-919 (2001).
15. Li Y., Matsunaga K., Kato R., Ohizumi Y., Nat. Med., 55, 90 (2001).
16. Li Y., Matsunaga K., Kato R., Ohizumi Y., J. Nat. Prod., 64, 806-808 (2001).
17. Li Y., Ishibashi M., Chen X., Ohizumi Y., Chem. Pharm. Bull., 51, 872-874 (2003).
18. Xing X., Padmanaban D., Yeh L. A., Cuny G. D., Tetrahedron, 58, 7903-7910 (2002).
19. Li Y., Chen X., Satake M., Oshima Y., Ohizumi Y., J. Nat. Prod., 67, 725-727 (2004).
20. Li Y., Ishibashi M., Satake M., Chen X., Oshima Y., Ohizumi Y., J. Nat. Prod., 66, 696-698 (2003).
21. Chanmahasathien W., Li Y., Satake M., Oshima Y., Ruangrungsi N., Ohizumi Y., Phytochemistry, 64, 981-986 (2003).
22. Chanmahasathien W., Li Y., Satake M., Oshima Y., Ishibashi M., Ruangrungsi N., Ohizumi Y., Chem. Pharm. Bull., 51, 1332-1334 (2003).